Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADJUVANT: Tirofiban vs Thrombolysis Before Thrombectomy in Acute Ischemic Stroke
NCT05728333Phase 3Completed
- Sponsor
- Xinqiao Hospital
- Start
- Nov 2023
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tirofiban in ischemic stroke, sponsored by Xinqiao Hospital. Started Nov 2023; status: completed.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05728333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05728333.